Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
多发性骨髓瘤中EZH2的过度表达与预后不良和细胞周期调控失调相关。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.27
Pawlyn, C; Bright, M D; Buros, A F; Stein, C K; Walters, Z; Aronson, L I; Mirabella, F; Jones, J R; Kaiser, M F; Walker, B A; Jackson, G H; Clarke, P A; Bergsagel, P L; Workman, P; Chesi, M; Morgan, G J; Davies, F E